Clostridioides difficile resilience linked to antibiotic resistance

Clostridioides difficile (C. diff) remains a significant health threat, particularly following antibiotic use. According to the Centers for Disease Control and Prevention (CDC), individuals are up to 10 times more likely to develop a C. diff infection while taking antibiotics and during the month following treatment. The infection occurs when antibiotics disrupt the gut microbiome, reducing beneficial bacteria and allowing C. diff to multiply and produce toxins that cause inflammation of the colon, known as colitis.

Recent research from Monash University has identified a link between antibiotic resistance and increased bacterial resilience. A study published in Nature Communications reveals that an antibiotic resistance gene can cause the bacterium to produce tougher spores. These spores are more capable of surviving hospital-grade disinfectants and high laundry temperatures, facilitating the spread of the pathogen through healthcare settings, homes, and the environment.